Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P8TS
|
||||
Former ID |
DIB001782
|
||||
Drug Name |
Eperisone
|
||||
Synonyms |
EMPP; Myonal; Myorelark; E-0646; E-2000; E-646; Eperisone (transdermal patch); Eperisone (oral), Eisai; Eperisone (transdermalpatch), Eisai; E-2000 (oral), Eisai; E-2000 (transdermal patch), Eisai
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Muscle spasm [ICD10:M62.838] | Phase 3 | [524606] | ||
Company |
Eisai Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C17H26ClNO
|
||||
Canonical SMILES |
C(=O)(C(CN1CCCCC1)C)c1ccc(cc1)CC
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Voltage-dependent calcium channel | Target Info | Modulator | [530122], [533095] | |
References | |||||
Ref 530122 | Inhibitory effect of glutamate release from rat cerebrocortical synaptosomes by dextromethorphan and its metabolite 3-hydroxymorphinan. Neurochem Int. 2009 Jul;54(8):526-34. | ||||
Ref 533095 | Suppression of calcium current in a snail neurone by eperisone and its analogues. Eur J Pharmacol. 1989 Sep 22;168(3):299-305. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.